Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03163667
Title CB-839 With Everolimus vs. Placebo With Everolimus in Patients With RCC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Calithera Biosciences, Inc
Indications

renal cell carcinoma

Therapies

Everolimus + Telaglenastat

Everolimus

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Arizona Cancer Center Tucson Arizona 85724 United States Details
Highlands Oncology Group Rogers Arkansas 72758 United States Details
Los Angeles Hematology Oncology Medical Group Los Angeles California 90017 United States Details
UCLA Department of Medicine - Hematology/Oncology Los Angeles California 90095 United States Details
Stanford Cancer Center Stanford California 94305 United States Details
Florida Cancer Specialists- South Fort Myers Florida 33901 United States Details
Florida Cancer Specialists- North Saint Petersburg Florida 33705 United States Details
University Cancer & Blood Center, LLC Athens Georgia 30607 United States Details
Northwest Georgia Oncology Centers, P.C. Marietta Georgia 30060 United States Details
St. Luke's Mountain States Tumor Institute Boise Idaho 83712 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Parkview Research Center Fort Wayne Indiana 46845 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
Norton Cancer Institute, Norton Healthcare Pavilion Louisville Kentucky 40202 United States Details
Ochsner Clinical Foundation New Orleans Louisiana 70121 United States Details
Anne Arundel Medical Center Oncology and Hematology Annapolis Maryland 21401 United States Details
University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 United States Details
Metro-Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota 55416 United States Details
Mercy Clinic Oncology & Hematology Joplin Missouri 64804 United States Details
SCRI HCA Midwest Kansas City Missouri 64132 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
St. Vincent Frontier Cancer Center Billings Montana 59102 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89148 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
North Shore Hematology Oncology Associates PC DBA NY Cancer and Blood Specialists East Setauket New York 11733 United States Details
NYU Winthrop Hospital - Cancer Clinical Trials Oncology/Hematology Mineola New York 11501 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
SUNY Upstate Medical University Syracuse New York 13210 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45219 United States Details
Ann B. Barshinger Cancer Institute / Lancaster General Hospital Lancaster Pennsylvania 17604 United States Details
Monongahela Valley Hospital Monongahela Pennsylvania 15063 United States Details
Charleston Hematology Oncology Associates,PA Charleston South Carolina 29414 United States Details
UT/Erlanger Oncology & Hematology Chattanooga Tennessee 37403 United States Details
Sarah Cannon Research Institute - Tennessee Oncology Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Utah Cancer Specialists Salt Lake City Utah 84106 United States Details
Wenatchee Valley Hospital and Clinics Wenatchee Washington 98801 United States Details
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field